HLHaneul Lee

Haneul Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haneul Lee has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Jimin Lee

    Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Korea

    1 shared publication
  • Kyong Hwa Park

    Division of Hemato-Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea

    1 shared publication
  • Su Jin Kang

    Department of Bioengineering and Nano-bioengineering, Incheon National University, Incheon 22012, Republic of Korea

    1 shared publication
  • Won Jong Rhee

    Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Isolation and Characterization of Urinary Extracellular Vesicles from Healthy Donors and Patients with Castration-Resistant Prostate Cancer

    by Haneul Lee, Su Jin Kang, Jimin Lee, Kyong Hwa Park, Won Jong Rhee

    Prostate cancer (PCa) is the most commonly diagnosed malignancy among men in developed countries. The five-year survival rate for men diagnosed with early-stage PCa is approximately 100%, while it is less than 30% for castration-resistant PCa (CRPC). Currently, the detection of prostate-specific antigens as biomarkers for the prognosis of CRPC is criticized because of its low accuracy, high invasiveness, and high false-positive rate. Therefore, it is important to identify new biomarkers for prediction of CRPC progression. Extracellular vesicles (EVs) derived from tumors have been highlighted as potential markers for cancer diagnosis and prognosis. Specifically, urinary EVs directly reflect changes in the pathophysiological conditions of the urogenital system because it is exposed to prostatic secretions. Thus, detecting biomarkers in urinary EVs provides a promising approach for performing an accurate and non-invasive liquid biopsy for CPRC. In this study, we effectively isolated urinary EVs with low protein impurities using size-exclusion chromatography combined with ultrafiltration. After EV isolation and characterization, we evaluated the miRNAs in urinary EVs from healthy donors and patients with CRPC. The results indicated that miRNAs (miR-21-5p, miR-574-3p, and miR-6880-5p) could be used as potential biomarkers for the prognosis of CRPC. This analysis of urinary EVs contributes to the fast and convenient prognosis of diseases, including CRPC, in the clinical setting.